KLOW is a research-use peptide blend combining GHK-Cu (Copper Tripeptide-1), TB-500 (a synthetic fragment of Thymosin Beta-4), and BPC-157 (a synthetic pentadecapeptide). Each component has been investigated in laboratory and preclinical settings for its role in cellular signaling and tissue-related pathways. When combined, this formulation is intended for research applications exploring synergistic peptide interactions. In controlled research environments, the individual components have been studied for their involvement in:
This website offers products strictly for Laboratory Research Use Only. Not for human consumption, medical, or veterinary use.